SFX by Ex Libris Inc.

Title:	In SituBlood–Brain Barrier Transport of Nanoparticles
Source:	Pharmaceutical Research [0724-8741] Koziara, Joanna yr:2003

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Lockman, Paul R. "In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles." Pharmaceutical Research 20.5 (2003): 705-713.
description	2.	Li, N. "Toxic Potential of Materials at the Nanolevel." Science 311.5761 (2006): 622-7.
description	3.	Linse, S. "Nucleation of protein fibrillation by nanoparticles." Proceedings of the National Academy of Sciences of the United States of America 104.21 (2007): 8691-8696.
description	4.	Yan, X. "RAGE: A potential target for Abeta-mediated cellular perturbation in Alzheimer's disease." Current molecular medicine 7.8 (2007): 735-742.
description	5.	Nassif, X. "How do extracellular pathogens cross the blood-brain barrier?" Trends in Microbiology 10.5 (2002): 227-232.
description	6.	Oberdorster, G. "Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles." Environmental health perspectives 113.7 (2005): 823-839.
description	7.	Xia, T. "Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm." Nano letters 6.8 (2006): 1794-1807.
description	8.	Nel, Andre E. "Understanding biophysicochemical interactions at the nano-bio interface." Nature Materials 8.7 (2009): 543-557.
description	9.	Service, Robert F F. "Nanotoxicology: Nanotechnology grows up." Science 304.5678 (2004): 1732-1734.
description	10.	Donaldson, K. Occupational and environmental medicine 61.9 (2004): 727-728.
description	11.	"essential oil: an efficient and safe alternative to preserve food, cosmetic and pharmaceutical products." Journal of applied microbiology. 122.4: 900-910.
description	12.	Hwang, J. "Development and Evaluation of Perfluorocarbon Nanobubbles for Apomorphine Delivery." Journal of pharmaceutical sciences 98.10 (2009): 3735-3747.
description	13.	Donahue, Edward G G. "RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease." Acta neuropathologica 112.4 (2006): 405-415.
description	14.	Lindman, S. "Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity." Nano letters 7.4 (2007): 914-920.
description	15.	Tacchi, S. "Structure, Stability, and Activity of Myoglobin Adsorbed onto Phosphate-Grafted Zirconia Nanoparticles." Langmuir 23.26 (2007): 13007-13012.
description	16.	Lockman, Paul R R. "Nanoparticle surface charges alter blood-brain barrier integrity and permeability." Journal of drug targeting 12.9-10: 635-641.
description	17.	Delaittre, G. "Nitroxide-mediated aqueous dispersion polymerization: From water-soluble macroalkoxyamine to thermosensitive nanogels." Macromolecular rapid communications 28.15 (2007): 1528-1533.
description	18.	Kogan, Marcelo J J. "Nanoparticle-mediated local and remote manipulation of protein aggregation." Nano letters 6.1 (2006): 110-115.
description	19.	Zheng, M. "Ethylene glycol monolayer protected nanoparticles for eliminating nonspecific binding with biological molecules." Journal of the American Chemical Society 125.26 (2003): 7790-7791.
description	20.	Kreuter, J. "Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles." Pharmaceutical Research 20.3 (2003): 409-16.